Maria Andersson, Karin Fröderberg Schooner, Viktor Karlsson Werther, Thomas Karlsson, Lina De Geer, Daniel B. Wilhelms, Martin Holmbom, Mats Fredrikson, Åse Östholm, Sören Berg, Håkan Hanberger
{"title":"对疑似败血症患者进行院前乳酸分析可提高对死亡风险增加患者的检测:一项观察性研究","authors":"Maria Andersson, Karin Fröderberg Schooner, Viktor Karlsson Werther, Thomas Karlsson, Lina De Geer, Daniel B. Wilhelms, Martin Holmbom, Mats Fredrikson, Åse Östholm, Sören Berg, Håkan Hanberger","doi":"10.1186/s13054-024-05225-2","DOIUrl":null,"url":null,"abstract":"Rapid, adequate treatment is crucial to reduce mortality in sepsis. Risk stratification scores used at emergency departments (ED) are limited in detecting all septic patients with increased mortality risk. We assessed whether the addition of prehospital lactate analysis to clinical risk stratification tools improves detection of patients with increased risk for rapid deterioration and death in sepsis. A10-month observational study with consecutive, prospective prehospital inclusion of adult patients with suspected sepsis. Prehospital lactate was used as a continuous variable and in intervals. Analyses of patient subgroups with high and lower priorities according to Rapid Emergency Triage and Treatment System (RETTS) and National Early Warning Score 2 (NEWS2) were performed. Primary outcome was 30-day mortality, secondary outcomes were sepsis at the ED and in-hospital mortality. In all, 714 patients were included with a 30-day mortality of 10%. Among the 322 cases (45%) fulfilling Sepsis-3 criteria, the 30-day mortality was 14%. Prehospital lactate was higher among non-survivors (2.6 vs 2.0 mmol/L, p < 0.001). Mortality at different lactate intervals were: 6.7%, at 0–2 mmol/l; 10.0% at > 2–3 mmol/l; 19.2% at > 3–4 mmol/l; and 17.0% at levels > 4 mmol/l. The highest RETTS priority (red) group had higher lactate levels than the lower (non-red) priority group (2.5 vs 1.9 mmol/L, p < 0.001). In the non-red group, prehospital lactate was higher among non-survivors (2.4 vs 1.8 mmol/L, p = 0.002). In the multivariable regression analysis, prehospital lactate > 3 mmol/l was a predictor of 30-day mortality (OR 2.20, p = 0.009) This association was even stronger in the lower priority RETTS non-red group (OR 3.02, p = 0.009). Adding prehospital lactate > 3 mmol/l increased identification of non-survivors from 48 to 68% in the RETTS red group and from 77 to 85% for the NEWS2 ≥ 7 group. The addition of a prehospital lactate level > 3 mmol/l improved early recognition of individuals with increased mortality risk in a cohort with suspected sepsis admitted to the ED. This was particularly evident in patients whose risk stratification scores did not indicate severe illness. We suggest that the addition of prehospital lactate analysis could improve recognition of subjects with suspected sepsis and increased mortality risk. ","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"46 1","pages":""},"PeriodicalIF":8.8000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prehospital lactate analysis in suspected sepsis improves detection of patients with increased mortality risk: an observational study\",\"authors\":\"Maria Andersson, Karin Fröderberg Schooner, Viktor Karlsson Werther, Thomas Karlsson, Lina De Geer, Daniel B. Wilhelms, Martin Holmbom, Mats Fredrikson, Åse Östholm, Sören Berg, Håkan Hanberger\",\"doi\":\"10.1186/s13054-024-05225-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rapid, adequate treatment is crucial to reduce mortality in sepsis. Risk stratification scores used at emergency departments (ED) are limited in detecting all septic patients with increased mortality risk. We assessed whether the addition of prehospital lactate analysis to clinical risk stratification tools improves detection of patients with increased risk for rapid deterioration and death in sepsis. A10-month observational study with consecutive, prospective prehospital inclusion of adult patients with suspected sepsis. Prehospital lactate was used as a continuous variable and in intervals. Analyses of patient subgroups with high and lower priorities according to Rapid Emergency Triage and Treatment System (RETTS) and National Early Warning Score 2 (NEWS2) were performed. Primary outcome was 30-day mortality, secondary outcomes were sepsis at the ED and in-hospital mortality. In all, 714 patients were included with a 30-day mortality of 10%. Among the 322 cases (45%) fulfilling Sepsis-3 criteria, the 30-day mortality was 14%. Prehospital lactate was higher among non-survivors (2.6 vs 2.0 mmol/L, p < 0.001). Mortality at different lactate intervals were: 6.7%, at 0–2 mmol/l; 10.0% at > 2–3 mmol/l; 19.2% at > 3–4 mmol/l; and 17.0% at levels > 4 mmol/l. The highest RETTS priority (red) group had higher lactate levels than the lower (non-red) priority group (2.5 vs 1.9 mmol/L, p < 0.001). In the non-red group, prehospital lactate was higher among non-survivors (2.4 vs 1.8 mmol/L, p = 0.002). In the multivariable regression analysis, prehospital lactate > 3 mmol/l was a predictor of 30-day mortality (OR 2.20, p = 0.009) This association was even stronger in the lower priority RETTS non-red group (OR 3.02, p = 0.009). Adding prehospital lactate > 3 mmol/l increased identification of non-survivors from 48 to 68% in the RETTS red group and from 77 to 85% for the NEWS2 ≥ 7 group. The addition of a prehospital lactate level > 3 mmol/l improved early recognition of individuals with increased mortality risk in a cohort with suspected sepsis admitted to the ED. This was particularly evident in patients whose risk stratification scores did not indicate severe illness. We suggest that the addition of prehospital lactate analysis could improve recognition of subjects with suspected sepsis and increased mortality risk. \",\"PeriodicalId\":10811,\"journal\":{\"name\":\"Critical Care\",\"volume\":\"46 1\",\"pages\":\"\"},\"PeriodicalIF\":8.8000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13054-024-05225-2\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13054-024-05225-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
快速、充分的治疗对于降低败血症的死亡率至关重要。急诊科(ED)使用的风险分层评分在检测所有死亡风险增加的脓毒症患者方面是有限的。我们评估了在临床风险分层工具中加入院前乳酸分析是否可以提高对脓毒症中快速恶化和死亡风险增加的患者的检测。一项为期10个月的观察性研究,对疑似脓毒症的成年患者进行了连续的前瞻性院前纳入研究。院前乳酸作为连续变量,间隔使用。根据快速紧急分类和治疗系统(RETTS)和国家预警评分2 (NEWS2)对优先级高低的患者亚组进行分析。主要结局是30天死亡率,次要结局是急诊科败血症和住院死亡率。总共有714名患者,30天死亡率为10%。在322例(45%)符合脓毒症-3标准的患者中,30天死亡率为14%。非幸存者院前乳酸水平较高(2.6 vs 2.0 mmol/L, p 2 ~ 3 mmol/L;3 ~ 4 mmol/l浓度为19.2%;在4 mmol/l水平下为17.0%。RETTS优先级最高(红色)组的乳酸水平高于较低(非红色)优先组(2.5 vs 1.9 mmol/L, p 3 mmol/L是30天死亡率的预测因子(OR 2.20, p = 0.009),这种关联在较低优先级RETTS非红色组中甚至更强(OR 3.02, p = 0.009)。院前添加乳酸bbbb3 mmol/l可使RETTS红组的非幸存者识别率从48%提高到68%,NEWS2≥7组的非幸存者识别率从77%提高到85%。院前乳酸水平bb0.3 mmol/l的增加提高了对急诊室疑似脓毒症患者死亡风险增加个体的早期识别。这在风险分层评分未显示严重疾病的患者中尤为明显。我们建议增加院前乳酸分析可以提高对疑似脓毒症患者的识别,并增加死亡风险。
Prehospital lactate analysis in suspected sepsis improves detection of patients with increased mortality risk: an observational study
Rapid, adequate treatment is crucial to reduce mortality in sepsis. Risk stratification scores used at emergency departments (ED) are limited in detecting all septic patients with increased mortality risk. We assessed whether the addition of prehospital lactate analysis to clinical risk stratification tools improves detection of patients with increased risk for rapid deterioration and death in sepsis. A10-month observational study with consecutive, prospective prehospital inclusion of adult patients with suspected sepsis. Prehospital lactate was used as a continuous variable and in intervals. Analyses of patient subgroups with high and lower priorities according to Rapid Emergency Triage and Treatment System (RETTS) and National Early Warning Score 2 (NEWS2) were performed. Primary outcome was 30-day mortality, secondary outcomes were sepsis at the ED and in-hospital mortality. In all, 714 patients were included with a 30-day mortality of 10%. Among the 322 cases (45%) fulfilling Sepsis-3 criteria, the 30-day mortality was 14%. Prehospital lactate was higher among non-survivors (2.6 vs 2.0 mmol/L, p < 0.001). Mortality at different lactate intervals were: 6.7%, at 0–2 mmol/l; 10.0% at > 2–3 mmol/l; 19.2% at > 3–4 mmol/l; and 17.0% at levels > 4 mmol/l. The highest RETTS priority (red) group had higher lactate levels than the lower (non-red) priority group (2.5 vs 1.9 mmol/L, p < 0.001). In the non-red group, prehospital lactate was higher among non-survivors (2.4 vs 1.8 mmol/L, p = 0.002). In the multivariable regression analysis, prehospital lactate > 3 mmol/l was a predictor of 30-day mortality (OR 2.20, p = 0.009) This association was even stronger in the lower priority RETTS non-red group (OR 3.02, p = 0.009). Adding prehospital lactate > 3 mmol/l increased identification of non-survivors from 48 to 68% in the RETTS red group and from 77 to 85% for the NEWS2 ≥ 7 group. The addition of a prehospital lactate level > 3 mmol/l improved early recognition of individuals with increased mortality risk in a cohort with suspected sepsis admitted to the ED. This was particularly evident in patients whose risk stratification scores did not indicate severe illness. We suggest that the addition of prehospital lactate analysis could improve recognition of subjects with suspected sepsis and increased mortality risk.
期刊介绍:
Critical Care is an esteemed international medical journal that undergoes a rigorous peer-review process to maintain its high quality standards. Its primary objective is to enhance the healthcare services offered to critically ill patients. To achieve this, the journal focuses on gathering, exchanging, disseminating, and endorsing evidence-based information that is highly relevant to intensivists. By doing so, Critical Care seeks to provide a thorough and inclusive examination of the intensive care field.